End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11.69 CNY | +1.12% | +6.66% | -22.89% |
08:43am | Huluwa Pharmaceutical Gets Nod to Register Two Drugs | MT |
Apr. 26 | Hainan Huluwa Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2022 | 1.52B 209M | Sales 2023 | 1.91B 263M | Capitalization | 6.07B 838M |
---|---|---|---|---|---|
Net income 2022 | 85M 11.74M | Net income 2023 | 106M 14.64M | EV / Sales 2022 | 4.37 x |
Net Debt 2022 | 204M 28.12M | Net Debt 2023 | 759M 105M | EV / Sales 2023 | 3.58 x |
P/E ratio 2022 |
76.3
x | P/E ratio 2023 |
56.1
x | Employees | 2,083 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 20.88% |
1 day | +1.12% | ||
1 week | +6.66% | ||
Current month | -4.96% | ||
1 month | -4.96% | ||
3 months | -12.70% | ||
6 months | -24.39% | ||
Current year | -22.89% |
Managers | Title | Age | Since |
---|---|---|---|
Jing Ping Liu
CEO | Chief Executive Officer | 54 | 07-11-30 |
Peng Xu
CHM | Chairman | 61 | 10-02-28 |
Hui Yu
DFI | Director of Finance/CFO | 40 | 22-07-07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gui Hua Wang
BRD | Director/Board Member | 63 | 18-11-15 |
Jing Ping Liu
CEO | Chief Executive Officer | 54 | 07-11-30 |
Ping Liu
BRD | Director/Board Member | 51 | 12-02-29 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 11.69 | +1.12% | 3,063,800 |
24-04-29 | 11.56 | +2.76% | 3,798,300 |
24-04-26 | 11.25 | +1.26% | 2,919,000 |
24-04-25 | 11.11 | +0.09% | 3,120,153 |
24-04-24 | 11.1 | -0.18% | 1,856,089 |
End-of-day quote Shanghai S.E., April 29, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-22.89% | 646M | |
+34.00% | 704B | |
+25.48% | 577B | |
-7.75% | 348B | |
+18.53% | 327B | |
+4.95% | 288B | |
+15.12% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-4.89% | 147B |
- Stock Market
- Equities
- 605199 Stock